Discounted Cash Flow
Resmed Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $1.8b | $352.4m | $489.4m | 19.2% | $2.51 |
| 2017 | $2.1b (12.4%) | $342.3m (-2.9%) | $351.8m (-28.1%) | 16.6% (-13.6%) | $2.42 (-3.6%) |
| 2018 | $2.3b (13.2%) | $315.6m (-7.8%) | $442.4m (25.8%) | 13.5% (-18.6%) | $2.21 (-8.7%) |
| 2019 | $2.6b (11.4%) | $404.6m (28.2%) | $390.3m (-11.8%) | 15.5% (15.1%) | $2.83 (28.1%) |
| 2020 | $3.0b (13.4%) | $621.7m (53.7%) | $706.9m (81.1%) | 21.0% (35.4%) | $4.31 (52.3%) |
| 2021 | $3.2b (8.1%) | $474.5m (-23.7%) | $634.0m (-10.3%) | 14.8% (-29.4%) | $3.27 (-24.1%) |
| 2022 | $3.6b (11.9%) | $779.4m (64.3%) | $216.3m (-65.9%) | 21.8% (46.8%) | $5.34 (63.3%) |
| 2023 | $4.2b (18.0%) | $897.6m (15.2%) | $573.6m (165.2%) | 21.3% (-2.4%) | $6.12 (14.6%) |
| 2024 | $4.7b (10.9%) | $1.0b (13.7%) | $1.3b (126.9%) | 21.8% (2.5%) | $6.94 (13.4%) |
| 2025 | $5.1b (9.8%) | $1.4b (37.2%) | $1.7b (27.6%) | 27.2% (24.9%) | $9.55 (37.6%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.